中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy

文献类型：期刊论文

作者Hou, Bo1,2,3; Zhou, Lei1,2; Wang, Hui3; Saeed, Madiha1,2; Wang, Dangge1,2; Xu, Zhiai4; Li, Yaping1,2; Yu, Haijun1,2
刊名ADVANCED MATERIALS
出版日期2020-02-12
页码11
关键词Boolean logic gates cancer immunotherapy prodrug nanoparticles stimuli activation tumor microenvironment
ISSN号0935-9648
DOI10.1002/adma.201907210
通讯作者Yu, Haijun(hjyu@simm.ac.cn)
英文摘要Prodrug nanoparticles that codeliver the immune modulators to the tumor site are highly recommendable for cancer immunotherapy yet remain challenging. However, effective stimuli-responsive strategies that exploit the endogenous hallmarks of the tumor have paved the way for cancer immunotherapy. For the first time, the development of the Boolean logic prodrug nanoparticles (BLPNs) for tumor-targeted codelivery of immune modulators (e.g., immune activator and immune inhibitor) and combination immunotherapy is reported herein. A library of stimuli-activatable BLPNs is fabricated yielding YES/AND logic outputs by adjusting the input combinations, including extracellular matrix metalloproteins 2/9 (MMP-2/9), intracellular acidity (pH = 5.0-6.0), and reduction (glutathione) in the tumor microenvironment. Tunable and selective control over BLPNs dissociation and prodrug activation is achieved by specifying the connectivity of orthogonal stimuli-labile spacers while exploiting the endogenous signals at the tumor sites. The tumor-specific distribution of the BLPNs and stimuli-activation of the immune modulators for highly efficient cancer immunotherapy are further demonstrated. The results reported in this study may open a new avenue for tumor-specific delivery of immune therapeutics and precise cancer immunotherapy.
WOS关键词T-CELLS ; MEMORY ; RESISTANCE ; THERAPY ; DESIGN
资助项目National Natural Science Foundation of China[31622025] ; National Natural Science Foundation of China[51873228] ; National Natural Science Foundation of China[31671024] ; National Natural Science Foundation of China[81521005] ; Youth Innovation Promotion Association of Chinese Academy of Sciences[2014218] ; CAS President's International Fellowship Initiative Program[2019PB0023] ; Open Research Fund of State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences[2019-027]
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
语种英语
WOS记录号WOS:000512716900001
出版者WILEY-V C H VERLAG GMBH
源URL[http://119.78.100.183/handle/2S10ELR8/281613]  
专题新药研究国家重点实验室
通讯作者Yu, Haijun
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, 501 Haike Rd, Shanghai 201203, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Pharmaceut, 501 Haike Rd, Shanghai 201203, Peoples R China
3.Inner Magnolia Univ, Coll Chem & Chem Engn, Hohhot 010021, Peoples R China
4.East China Normal Univ, Sch Chem & Mol Engn, Shanghai 200241, Peoples R China
推荐引用方式
GB/T 7714		 Hou, Bo,Zhou, Lei,Wang, Hui,et al. Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy[J]. ADVANCED MATERIALS,2020:11.
APA Hou, Bo.,Zhou, Lei.,Wang, Hui.,Saeed, Madiha.,Wang, Dangge.,...&Yu, Haijun.(2020).Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy.ADVANCED MATERIALS,11.
MLA Hou, Bo,et al."Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy".ADVANCED MATERIALS (2020):11.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。